Susruta Majumdar

Title: Innovations and Contributions of Susruta Majumdar

Introduction

Susruta Majumdar is a notable inventor based in Stamford, CT, who has made significant contributions to the field of pharmacology. With a total of five patents to his name, he has focused on developing innovative compounds aimed at improving pain relief and reducing the side effects associated with traditional opioid medications.

Latest Patents

Among his latest patents is a groundbreaking development in G-protein biased opioid receptor agonists and analgesics with reduced arrestin recruitment. This invention provides compounds that may effectively reduce pain in patients while offering an improved pharmaceutical profile compared to commonly used opiates and opioid derivatives. Another significant patent involves ligands of the mu, kappa, and delta opioid receptors. This invention is based on molecular dynamics simulations of conformational states of the mu opioid receptor, leading to the discovery of new opioid receptor ligands that can be utilized as analgesics, anti-diarrheal agents, and overdose reversal agents.

Career Highlights

Susruta Majumdar has worked at prestigious institutions such as Memorial Sloan Kettering Cancer Center and the Sloan Kettering Institute for Cancer Research. His work in these organizations has allowed him to contribute to cutting-edge research in cancer treatment and pain management.

Collaborations

Throughout his career, Susruta has collaborated with esteemed colleagues, including Gavril W. Pasternak and Rashad Karimov. These collaborations have further enhanced his research and development efforts in the field of opioid receptor ligands.

Conclusion

Susruta Majumdar's innovative work in the development of opioid receptor ligands and analgesics showcases his commitment to improving pain management therapies. His contributions are paving the way for safer and more effective pain relief options for patients.